China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)
Company Info
BMG210A71016
Dec 19, 1995
Highlights
HK$21.12B
8.49
HK$6.05B
HK$3.59B
HK$1.62B
HK$3.86 - HK$7.24
HK$7.23
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in China Grand Pharmaceutical and Healthcare Holdings Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK) returned 54.94% year-to-date (YTD) and 65.13% over the past 12 months. Over the past 10 years, 0512.HK delivered an annualized return of 15.43%, outperforming the S&P 500 benchmark at 10.43%.
0512.HK
54.94%
29.12%
57.90%
65.13%
9.81%
15.43%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of 0512.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -12.08% | 19.20% | 19.88% | 3.39% | 19.30% | 54.94% | |||||||
| 2024 | -17.60% | 6.53% | 14.49% | 5.60% | 13.59% | -0.53% | -4.09% | -1.12% | 17.91% | -12.31% | -0.66% | 5.96% | 23.77% |
| 2023 | 6.09% | -8.61% | 1.12% | 13.08% | -0.39% | -10.30% | 0.23% | -8.35% | 3.45% | 0.24% | 5.46% | -7.88% | -8.33% |
| 2022 | -14.40% | 11.57% | -9.89% | -12.77% | -11.34% | 8.50% | -4.40% | -3.23% | -19.29% | -0.89% | 22.32% | 11.92% | -26.82% |
| 2021 | -8.72% | -1.27% | -0.48% | 5.67% | 24.08% | -8.99% | -14.88% | 0.32% | 0.16% | 0.65% | 2.24% | 1.09% | -4.78% |
| 2020 | 16.04% | 0.40% | -6.88% | 11.74% | 3.89% | 3.72% | 34.93% | -3.68% | 0.43% | -11.27% | 7.14% | 1.92% | 65.20% |
| 2019 | 16.48% | 17.99% | -0.00% | -6.10% | -0.43% | 0.42% | -7.06% | -1.66% | -0.24% | 8.96% | -1.56% | -4.29% | 20.77% |
| 2018 | 28.34% | 8.79% | -5.64% | 17.33% | 4.92% | -10.68% | -4.37% | 2.86% | -6.11% | -25.05% | 5.26% | -10.50% | -5.52% |
| 2017 | -1.32% | 11.33% | 14.37% | 10.47% | 3.79% | -6.39% | 2.93% | 26.06% | 1.88% | 5.90% | 9.06% | 21.73% | 150.66% |
| 2016 | -11.96% | -2.47% | 5.69% | -1.19% | -6.67% | -10.40% | 3.63% | 6.99% | 7.19% | -1.22% | -0.00% | -6.17% | -17.39% |
| 2015 | -8.44% | -0.71% | 17.14% | 31.10% | 10.70% | -9.24% | -6.02% | -10.84% | 6.08% | 1.04% | -2.58% | -2.65% | 19.47% |
| 2014 | 77.51% | 2.81% | -4.11% | 1.43% | -3.52% | 8.03% | -0.68% | 8.16% | 0.63% | 10.62% | -6.78% | -6.67% | 92.51% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 93, 0512.HK is among the top 7% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
China Grand Pharmaceutical and Healthcare Holdings Ltd provided a 7.31% dividend yield over the last twelve months, with an annual payout of HK$0.52 per share. The company has been increasing its dividends for 5 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Dividend | HK$0.52 | HK$0.26 | HK$0.14 | HK$0.11 | HK$0.11 | HK$0.10 | HK$0.09 |
Dividend yield | 7.31% | 5.42% | 3.42% | 2.39% | 1.70% | 1.40% | 2.03% |
Monthly Dividends
The table displays the monthly dividend distributions for China Grand Pharmaceutical and Healthcare Holdings Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.26 | HK$0.00 | HK$0.26 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.26 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.26 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.14 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.14 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 |
| 2019 | HK$0.09 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.09 |
Dividend Yield & Payout
Dividend Yield
China Grand Pharmaceutical and Healthcare Holdings Ltd has a dividend yield of 7.31%, which means its dividend payment is significantly above the market average.
Payout Ratio
China Grand Pharmaceutical and Healthcare Holdings Ltd has a payout ratio of 36.88%, which is quite average when compared to the overall market. This suggests that China Grand Pharmaceutical and Healthcare Holdings Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the China Grand Pharmaceutical and Healthcare Holdings Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the China Grand Pharmaceutical and Healthcare Holdings Ltd was 99.52%, occurring on Sep 5, 2006. The portfolio has not yet recovered.
The current China Grand Pharmaceutical and Healthcare Holdings Ltd drawdown is 37.37%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.52% | Mar 6, 1996 | 1905 | Sep 5, 2006 | — | — | — |
| -11.64% | Jan 26, 1996 | 10 | Feb 8, 1996 | 14 | Mar 4, 1996 | 24 |
| -2.33% | Jan 11, 1996 | 2 | Jan 12, 1996 | 2 | Jan 16, 1996 | 4 |
| -0.66% | Jan 19, 1996 | 1 | Jan 19, 1996 | 1 | Jan 22, 1996 | 2 |
Volatility
Volatility Chart
The current China Grand Pharmaceutical and Healthcare Holdings Ltd volatility is 20.68%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of China Grand Pharmaceutical and Healthcare Holdings Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of China Grand Pharmaceutical and Healthcare Holdings Ltd, comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.
Valuation
The Valuation section provides an overview of how China Grand Pharmaceutical and Healthcare Holdings Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 0512.HK, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0512.HK has a P/E ratio of 8.5. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 0512.HK compared to other companies in the Drug Manufacturers - Specialty & Generic industry. 0512.HK currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 0512.HK relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0512.HK has a P/S ratio of 1.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 0512.HK in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 0512.HK has a P/B value of 1.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |